NIH's IRSDA (PAR-28-040) Buys Early-Career PIs Up to $140K a Year to Build a Global Health Research Career

For the early-career academic PI eyeing a global health research career, the NIH's International Research Scientist Development Award (IRSDA, PAR-28-040) now offers up to $140,000 a year in salary and research support on rolling K-series deadlines, per the Grants.gov listing at grants.gov/search-results-detail/363050.

It is one of the few federal career-development awards built specifically for scientists who want to do their fieldwork abroad — and it has been quietly running since 1999 without much competition from applicants who assume it is out of reach.

What PAR-28-040 actually funds

The full announcement lives at grants.gov/search-results-detail/363050, where the IRSDA is listed under activity code K01 and administered by the John E. Fogarty International Center, the arm of the NIH devoted to global health. The award is a mentored career-development grant, not a project grant. Its purpose is narrow and unusually concrete: to take an advanced postdoc or a newly appointed junior faculty member and give them three to five years of protected time to become an independent investigator working on the health priorities of a low- or middle-income country (LMIC).

The money reflects that structure. IRSDA provides up to $100,000 per year in salary support plus fringe benefits, and up to $40,000 per year toward research development costs — supplies, travel, small-scale data collection, the machinery of actually running a study in the field. Facilities and administrative costs are reimbursed at a flat 8% of modified total direct costs, the standard rate for K awards routed through foreign and career-development mechanisms. Over a five-year award, that is well north of half a million dollars in salary alone, before research costs, all earmarked to buy a young scientist time.

That "protected time" language is not decorative. IRSDA awardees are required to commit 75% of their full-time professional effort to the award. The point is to wall the recipient off from the teaching loads, clinical shifts, and service obligations that usually swallow a junior faculty member's first years and stall the transition to independent funding.

The in-country requirement is the whole point

What separates IRSDA from a garden-variety K01 is geography. Awardees must spend a minimum of 50% of their cumulative effort across the life of the award physically in-country, conducting collaborative research at the LMIC institution. On top of that, every single year of the award requires at least three months on the ground at the foreign site.

This is a hard line, and it is worth reading twice before applying. IRSDA is not a mechanism for running an LMIC study by remote control from a U.S. campus. The Fogarty Center designed it around the belief that durable global health research capacity gets built by people who are actually present — who train local staff, sit in the clinics, and stay long enough for a collaboration to outlast a single grant cycle. The structural requirement of dual mentorship reinforces that: each applicant must line up both a U.S.-based primary mentor and an LMIC-based primary mentor. The award is, in effect, a bet on a two-institution relationship, not just on an individual.

For the right candidate, that is a feature rather than a hurdle. A scientist who already has a field site, a foreign collaborator, and a research question rooted in a specific country's health burden will find IRSDA fits their trajectory almost exactly. For someone who is merely curious about global health and hoping the grant will fund the exploration, the 50%-in-country rule is a filter that will screen them out fast.

Who is eligible — and who is not

The eligibility criteria are specific enough to disqualify a lot of otherwise strong applicants, so they are worth stating plainly. Candidates must be U.S. citizens, nationals, or permanent residents at the time of application. They must hold a research or health-professional doctoral degree — PhD, MD, DrPH, DVM, or equivalent — and have accumulated at least two years of research experience beyond that degree. They need a full-time appointment at the applicant institution and must be able to commit the 75% effort described above.

There is a companion structure worth understanding. The IRSDA is issued as a pair of announcements: one for projects that involve leading an independent clinical trial (PAR-28-040's clinical-trial-required track, mirrored in the earlier PAR-24-114) and one for projects where an independent clinical trial is not allowed. If your career-development plan hinges on running a trial, you apply under the clinical-trial-required version; if it does not, you apply under the other. Picking the wrong one is a common and avoidable way to get an application administratively returned before review.

The sponsoring institutes matter for fit, too. While Fogarty administers the program, participating NIH institutes co-fund it — the National Cancer Institute and the National Institute on Deafness and Other Communication Disorders are among those listed on recent cycles. A candidate whose research aligns with a co-sponsoring institute's mission has a materially better shot, because that institute has budget earmarked and reviewers who care about the topic.

Rolling deadlines change how you should plan

The most practical detail for anyone reading this in July is that IRSDA does not run on a single annual cliff. As a K-series award, it accepts new applications on the NIH standard due dates — February 12, June 12, and October 12 — which means the next window after this summer closes on October 12, 2026, with subsequent cycles following in February and June of 2027. Applications are due by 5:00 p.m. local time of the applicant organization.

Three cycles a year sounds relaxed. It is not, because the real work of an IRSDA application is not the writing — it is assembling the two-mentor, two-institution partnership and getting a foreign institution's letters, budget, and commitments in order. That coordination runs on international mail, time zones, and the availability of collaborators who are themselves running clinics. A realistic timeline treats the October 12 deadline as something you start building toward in July, not September. The rolling calendar is a gift only to applicants who use the lead time; for everyone else it is three chances a year to submit something half-ready.

Why this one is worth a serious look

Career-development awards are the least glamorous line in the NIH catalog and, for the right person, the highest-leverage. A K01 does not fund a splashy result. It funds the years in which a scientist stops being someone else's trainee and becomes a principal investigator with their own agenda, their own site, and their own track record of independent funding — the exact prerequisites for an eventual R01. The IRSDA compresses that transition and attaches it to a mission — building research capacity in the places that carry the heaviest disease burden and the thinnest scientific infrastructure — that a lot of early-career researchers say they went into science to serve.

The award has been running for more than 25 years and has produced a well-documented alumni pipeline of investigators who went on to lead independent global health programs. It is also, relative to the open R-series competition, an under-subscribed mechanism — the eligibility filters and the in-country requirement thin the applicant pool considerably, which quietly improves the odds for candidates who genuinely fit. That combination — real money, protected time, a defined mission, and a smaller field — is rare in the federal funding landscape. If you have a doctoral degree, two years of post-doc research, a foreign collaborator, and a health question rooted in a specific country, PAR-28-040 may be the most efficient path to independence available to you.

Before you commit weeks to an application, it is worth mapping the surrounding funding landscape — the companion clinical-trial track, related Fogarty mechanisms, and the co-sponsoring institutes' own K awards — so you apply under the announcement that actually fits your plan. Granted's team publishes plain-English breakdowns of federal career and research awards on the Granted blog, and the discovery tools below will surface the active solicitations that overlap with your work.

Next step: Search active NIH career-development and global health awards on Granted to see which mechanisms — including the IRSDA and its co-sponsoring institutes' K awards — are open on the current cycle, then line up your mentors before the October 12 deadline.